[ad_1] Biogen Inc. and Eisai Co. late Wednesday released new data on their Alzheimer’s treatment…
Neurodegenerative Disease Drugs
-
-
STOCK MARKET
Cassava shares plummet after investigation accuses researcher of ‘egregious misconduct’
by userby user[ad_1] Shares of biotech company Cassava Sciences Inc. were slammed in extended trading Thursday, after…
-
[ad_1] Biogen Inc. BIIB, -4.23% said Tuesday that it will eliminate about 1,000 jobs as…
-
STOCK MARKET
Acadia stock rallies on drug news as Roivant also climbs, while Leslie’s, Theseus shares plunge and more moving stocks
by userby user[ad_1] Here are some of the biggest movers ahead of Friday’s market open: Stock gainers:…
-
STOCK MARKET
FDA approves Alzheimer’s treatment Leqembi, clearing the way for Medicare coverage
by userby user[ad_1] The U.S. Food and Drug Administration on Thursday granted full approval to the Biogen…
-
STOCK MARKET
Biogen stock climbs on drug approval recommendation, Oracle shares rise ahead of earnings, and other stocks on the move
by userby user[ad_1] Here are some of the biggest movers of Monday. Stock gainers: Biogen Inc. shares…
-
STOCK MARKET
Eisai shares rise as FDA memo raises hopes for full approval of Alzheimer’s drug
by userby user[ad_1] Eisai shares 4523, +8.77% rose sharply Thursday morning after the U.S. Food and Drug…
-
[ad_1] Medicare on Thursday announced plans for coverage of new Alzheimer’s drugs whose accessibility has…
-
STOCK MARKET
Eli Lilly on track to close with a higher market cap than J&J for first time since 1997
by userby user[ad_1] Eli Lilly & Co. was on track Friday to close with a greater market…
-
STOCK MARKET
Good results from Alzheimer’s drug trial seen as ‘potentially very important’
by userby user[ad_1] Positive results from an Alzheimer’s trial by Eli Lilly are seen as a very…